134271-93-5 Usage
Description
1-(3-nitrophenyl)-2-propylidenehydrazine is a chemical compound with the molecular formula C10H13N3O2. It is a hydrazine derivative featuring a nitrophenyl group and a propylidene group attached to a hydrazine moiety. 1-(3-nitrophenyl)-2-propylidenehydrazine is recognized for its potential applications in the pharmaceutical industry and as a building block for synthesizing various organic compounds. It has been investigated for its possible biological activities, including its potential as an anti-tuberculosis agent. However, due to the presence of a hydrazine moiety, it is crucial to handle this chemical with care and adhere to proper safety protocols in a laboratory environment.
Uses
Used in Pharmaceutical Industry:
1-(3-nitrophenyl)-2-propylidenehydrazine is used as a pharmaceutical intermediate for the synthesis of various organic compounds. Its unique structure allows it to serve as a key component in the development of new drugs and pharmaceuticals.
Used in Organic Synthesis:
In the field of organic chemistry, 1-(3-nitrophenyl)-2-propylidenehydrazine is used as a building block for creating a range of organic compounds. Its versatile structure makes it a valuable asset in the synthesis of complex molecules.
Used in Anti-tuberculosis Research:
1-(3-nitrophenyl)-2-propylidenehydrazine is also utilized in the research and development of potential anti-tuberculosis agents. Its biological activities are being studied to determine its effectiveness in combating tuberculosis, a significant global health concern.
Check Digit Verification of cas no
The CAS Registry Mumber 134271-93-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,4,2,7 and 1 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 134271-93:
(8*1)+(7*3)+(6*4)+(5*2)+(4*7)+(3*1)+(2*9)+(1*3)=115
115 % 10 = 5
So 134271-93-5 is a valid CAS Registry Number.
134271-93-5Relevant articles and documents
METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION
-
Paragraph 0673, (2021/04/02)
Mutations in oncogenes and tumor suppressors contribute to the development and progression of cancer. The present disclosure describes compounds and methods to recover wild-type function to p53 mutants. The compounds of the present invention can bind to mutant p53 and restore the ability of the p53 mutant to bind DNA and activate downstream effectors involved in tumor suppression. The disclosed compounds can be used to reduce the progression of cancers that contain a p53 mutation.
Compositions for Treatment of Cystic Fibrosis and Other Chronic Diseases
-
Paragraph 0414; 1633, (2015/09/22)
The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.
COMPOSITIONS FOR TREATMENT OF CYSTIC FIBROSIS AND OTHER CHRONIC DISEASES
-
, (2012/04/23)
The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.
